Alcobra Ltd. (ADHD) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. SPY
6. RMR
7. DVN
8. GOOG
9. ANGO
10. LULU

Go back to Alcobra Ltd. (ADHD) Tops Q2 EPS by 5c

Alcobra Announces Second Quarter 2015 Financial Results and Provides Corporate Update

August 13, 2015 7:00 AM EDT

Conference Call & Webcast today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time

TEL AVIV, Israel, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq: ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced financial results for the three and six months ended June 30, 2015, and provided a corporate update.

Second Quarter Ended June 30, 2015 Financial Results:

Total operating expenses were $5.2 million, similar to the first quarter... More